111 related articles for article (PubMed ID: 21472216)
1. The effects of MAPK inhibitors on antimycin A-treated calf pulmonary arterial endothelial cells in relation to cell death, reactive oxygen species and glutathione.
Han YH; You BR; Moon HJ; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2010; 3(1):161-6. PubMed ID: 21472216
[TBL] [Abstract][Full Text] [Related]
2. The effects of antimycin A on endothelial cells in cell death, reactive oxygen species and GSH levels.
You BR; Park WH
Toxicol In Vitro; 2010 Jun; 24(4):1111-8. PubMed ID: 20332020
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of propyl gallate-induced calf pulmonary arterial endothelial cell death by MEK and JNK inhibitors.
Han YH; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2009; 2(5):825-30. PubMed ID: 21475908
[TBL] [Abstract][Full Text] [Related]
4. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
You BR; Park WH
J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
[TBL] [Abstract][Full Text] [Related]
5. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
6. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
Park WH
Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
[TBL] [Abstract][Full Text] [Related]
7. JNK and p38 inhibitors increase and decrease apoptosis, respectively, in pyrogallol-treated calf pulmonary arterial endothelial cells.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2009 Nov; 24(5):717-22. PubMed ID: 19787207
[TBL] [Abstract][Full Text] [Related]
8. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.
You BR; Park WH
Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830
[TBL] [Abstract][Full Text] [Related]
9. MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition.
Park WH
Mol Med Rep; 2011; 4(1):193-04. PubMed ID: 21461585
[TBL] [Abstract][Full Text] [Related]
10. p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Nov; 29(11):4423-31. PubMed ID: 20032388
[TBL] [Abstract][Full Text] [Related]
11. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
12. The effects of MAPK inhibitors on antimycin A-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species, and glutathione.
Han YH; Park WH
Mol Cell Biochem; 2010 Jan; 333(1-2):211-9. PubMed ID: 19714450
[TBL] [Abstract][Full Text] [Related]
13. Pyrogallol-induced endothelial cell death is related to GSH depletion rather than ROS level changes.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Oncol Rep; 2010 Jan; 23(1):287-92. PubMed ID: 19956894
[TBL] [Abstract][Full Text] [Related]
14. The MEK inhibitor PD98059 attenuates growth inhibition and death in gallic acid-treated Calu-6 lung cancer cells by preventing glutathione depletion.
Han YH; Moon HJ; You BR; Yang YM; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2010; 3(3):519-25. PubMed ID: 21472273
[TBL] [Abstract][Full Text] [Related]
15. Pyrogallol-induced calf pulmonary arterial endothelial cell death via caspase-dependent apoptosis and GSH depletion.
Han YH; Park WH
Food Chem Toxicol; 2010 Feb; 48(2):558-63. PubMed ID: 19913593
[TBL] [Abstract][Full Text] [Related]
16. Propyl gallate inhibits the growth of calf pulmonary arterial endothelial cells via glutathione depletion.
Han YH; Moon HJ; You BR; Park WH
Toxicol In Vitro; 2010 Jun; 24(4):1183-9. PubMed ID: 20159035
[TBL] [Abstract][Full Text] [Related]
17. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Park WH
Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
[TBL] [Abstract][Full Text] [Related]
18. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
Park WH; Kim SH
Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
[TBL] [Abstract][Full Text] [Related]
19. Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2010 Jan; 25(1):121-8. PubMed ID: 19956910
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death.
Han YH; Kim SZ; Kim SH; Park WH
Drug Chem Toxicol; 2010 Oct; 33(4):403-9. PubMed ID: 20088736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
